Last update 29 Mar 2025

AMT-110

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
AMT 110, AMT110, RAAV2/5-HNAGLU
Target
NAGLU
Action-
Mechanism
NAGLU replacements(Alpha-N-acetylglucosaminidase replacements), Gene transference
Therapeutic Areas
Other DiseasesCongenital DisordersEndocrinology and Metabolic Disease+ [1]
Active Indication
Mucopolysaccharidosis III
Inactive Indication
Lower Urinary Tract Symptoms
Originator Organization
Institut PasteurInstitut PasteurAmsterdam Molecular Therapeutics BV
Active Organization
Institut PasteurInstitut Pasteur
Inactive Organization
Recordati SpARecordati SpAuniQure biopharma BV
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with AMT-110
NCT03300453
/ CompletedPhase 1/2
Protocol AMT110-CD-001: A Phase I/II, Open-label, Study of Intracerebral Administration of Adeno-associated Viral Vector Containing the Human Alpha-N-acetylglucosaminidase cDNA in Children With Sanfilippo Type B Syndrome
100 Clinical Results associated with AMT-110
Login to view more data
100 Translational Medicine associated with AMT-110
Login to view more data
100 Patents (Medical) associated with AMT-110
Login to view more data
100 Deals associated with AMT-110
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Lower Urinary Tract SymptomsPhase 3
Germany
Recordati SpARecordati SpA
01 Sep 2013
Lower Urinary Tract SymptomsPhase 3
Italy
Recordati SpARecordati SpA
01 Sep 2013
Lower Urinary Tract SymptomsPhase 3
Poland
Recordati SpARecordati SpA
01 Sep 2013
Lower Urinary Tract SymptomsPhase 3
Spain
Recordati SpARecordati SpA
01 Sep 2013
Lower Urinary Tract SymptomsPhase 3
United Kingdom
Recordati SpARecordati SpA
01 Sep 2013
Mucopolysaccharidosis IIIPhase 2
France
uniQure biopharma BV
17 Sep 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free